- Home
- IKT vs TGE Comparison
IKT vs TGE Comparison
Compare IKT & TGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- TGE
- Stock Information
- Founded
- IKT 2008
- TGE 2023
- Country
- IKT United States
- TGE France
- Employees
- IKT N/A
- TGE N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- TGE Newspapers/Magazines
- Sector
- IKT Health Care
- TGE Consumer Discretionary
- Exchange
- IKT Nasdaq
- TGE Nasdaq
- Market Cap
- IKT 140.5M
- TGE 152.2M
- IPO Year
- IKT 2020
- TGE N/A
- Fundamental
- Price
- IKT $1.56
- TGE $2.76
- Analyst Decision
- IKT Buy
- TGE
- Analyst Count
- IKT 2
- TGE 0
- Target Price
- IKT $8.00
- TGE N/A
- AVG Volume (30 Days)
- IKT 92.1K
- TGE 933.6K
- Earning Date
- IKT 11-13-2025
- TGE 02-12-2020
- Dividend Yield
- IKT N/A
- TGE N/A
- EPS Growth
- IKT N/A
- TGE N/A
- EPS
- IKT N/A
- TGE 1.64
- Revenue
- IKT N/A
- TGE $77,014,000.00
- Revenue This Year
- IKT N/A
- TGE N/A
- Revenue Next Year
- IKT N/A
- TGE N/A
- P/E Ratio
- IKT N/A
- TGE $1.58
- Revenue Growth
- IKT N/A
- TGE 81.03
- 52 Week Low
- IKT $1.12
- TGE $2.47
- 52 Week High
- IKT $4.20
- TGE $37.02
- Technical
- Relative Strength Index (RSI)
- IKT 42.51
- TGE N/A
- Support Level
- IKT $1.50
- TGE N/A
- Resistance Level
- IKT $1.73
- TGE N/A
- Average True Range (ATR)
- IKT 0.09
- TGE 0.00
- MACD
- IKT -0.02
- TGE 0.00
- Stochastic Oscillator
- IKT 17.34
- TGE 0.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About TGE The Generation Essentials Group Class A Ordinary Shares
The Generation Essentials Group is a media and entertainment company. Its publications L'Officiel and The Art Newspaper publish print editions in a total of nearly 28 countries and territories and digital contents. It operate in the movie production sector having produced various Asia-focused movies. It operate in three operating segments: media and entertainment segment, hotel operations, hospitality and VIP services segment and strategic investment segment. Key revenue is generated from strategic investment segment that is engage in proprietary investments and management of portfolio, including listed and unlisted equity shares investments and movie income right investments.